Skip to main content

BioRestorative Therapies, Inc. (BRTX)

NASDAQ: BRTX · IEX Real-Time Price · USD
5.22
-0.52 (-9.06%)
At close: Dec 3, 2021 4:00 PM
5.15
-0.07 (-1.34%)
After-hours:Dec 3, 2021 7:45 PM EST
Market Cap4.38M
Revenue (ttm)58,000
Net Income (ttm)-29.66M
Shares Out838,689
EPS (ttm)-40.82
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume146,801
Open5.60
Previous Close5.74
Day's Range5.15 - 5.78
52-Week Range5.15 - 8.90
Beta83.77
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BRTX

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100 that has completed Phase 1 clinical trials is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone...

IndustryBiotechnology
Founded1997
CEOMark Weinreb
Employees5
Stock ExchangeNASDAQ
Ticker SymbolBRTX
Full Company Profile

Financial Performance

In 2020, BRTX's revenue was $77,000, a decrease of -40.77% compared to the previous year's $130,000. Losses were -$11.27 million, -23.04% less than in 2019.

Financial Statements

News

BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program

MELVILLE, N.Y., Dec. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ: BRTX ), a life sciences company focused on adult stem cell-based therapies, ...

2 days ago - GlobeNewsWire

BioRestorative Therapies Enters into Letter of Intent with PRC Clinical

PRC Clinical to Provide Start-up CRO Services for BRTX-100 Phase 2 Clinical Trial

2 weeks ago - GlobeNewsWire

BioRestorative Therapies Appoints Robert Kristal as Chief Financial Officer

MELVILLE, N.Y., Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (NASDAQ: BRTX ), a life sciences company focused on adult stem cell-based therapies, today announced that...

3 weeks ago - GlobeNewsWire

BioRestorative Therapies Announces Closing of $23 Million Public Offering

MELVILLE, N.Y., Nov. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced the cl...

3 weeks ago - GlobeNewsWire

BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market

Common stock will begin trading on The Nasdaq Capital Market under the ticker symbol “BRTX” November 5, 2021

4 weeks ago - GlobeNewsWire

BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program

MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“ BioRestorative ” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today a...

2 months ago - GlobeNewsWire

BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program

Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use

3 months ago - GlobeNewsWire

BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program

Patent Issued Grants Protection for Deriving Brown Adipocytes from Brown Adipose (Fat)-Derived Stem Cells

3 months ago - GlobeNewsWire

BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook

MELVILLE, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced ...

3 months ago - GlobeNewsWire

BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering

MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX ), a life sciences company focused on stem cell-based therapies, today announced that it ha...

3 months ago - GlobeNewsWire

BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021

BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference.

5 months ago - GlobeNewsWire

BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility

MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX ), a life sciences company focused on stem cell-based therapies, today anno...

6 months ago - GlobeNewsWire

BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal

MELVILLE, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today annou...

7 months ago - GlobeNewsWire

BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors

MELVILLE, N.Y., April 05, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today ann...

7 months ago - GlobeNewsWire

BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf Ther...

Notice of Allowance Grants Protection for Deriving Exosomes from Brown Adipocytes Notice of Allowance Grants Protection for Deriving Exosomes from Brown Adipocytes

8 months ago - GlobeNewsWire

BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoSte...

MELVILLE, N.Y., March 22, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Unit...

8 months ago - GlobeNewsWire

BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K

MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced...

8 months ago - GlobeNewsWire